Region: Germany

Second medical use claims in pharmaceutical patents – sharp sword or toothless tiger?

Featured in IAM Innovation & Invention Yearbook 2021

Discovering a previously unknown indication for a known drug is a common pattern in pharmaceutical research and development. Perhaps the most widely known example for the repurposing of a known drug is acetylsalicylic acid, also known as aspirin.

20 November 2020

A deep dive into EPO opposition representation reveals Germany and the UK dominate

Proceedings are on the increase, with the Germans holding sway against an increasing British challenge

18 November 2020

A blissful summer for SEP owners

The licensing community had much to enjoy over the summer months, from key court decisions in the United States and Europe to positive policy developments

04 November 2020

Roundtable: Essential reading

SEPs were never far from the headlines in Summer 2020. Experts discuss some of the most

04 November 2020

Nokia secures second German injunction ruling against Daimler, while details emerge of “major” patent licence renewal

Finnish telco prevails in Munich case with bond set well below previous sales ban

30 October 2020

Deutsche Telekom looks to inject new life into patent auctions with December sale

Online process will see the German company attempt to offload portfolio reading on smart traffic and navigation technology

29 October 2020

Multi-billion dollar Bayer deal shows growing attraction of gene and cell therapy assets

AskBio buyout highlights new transaction patterns around cutting-edge biotech innovations

29 October 2020

Remembering a blissful summer for SEP owners

As the weather turns wet and cold in the Northern Hemisphere, licensors can look back on a memorable streak of major wins in the period from July through to September

21 October 2020

Patent sale may have helped seal big Sharp Huawei auto licence

Transfer shows Hon Hai Group is betting on its own ability to license key wireless technology developed by Sharp

20 October 2020

Xiaomi’s Paul Lin: video implementers must work together to avoid standard dysfunction

Company’s IP strategy chief says cost of codec licensing not justified by the state of the technology

08 October 2020

Unlock unlimited access to all IAM content